|
Abviva aims to bring better diagnostics to the fight against breast cancer. The drug developer (formerly known as Genesis Bioventures) is working on proteomics-based cancer diagnostics and therapeutics. Its wholly owned subsidiary Biomedical Diagnostics has developed a blood test, called the Mammastatin Serum Assay, which assesses a person's risk for developing breast cancer. Abviva also has a significant stake in Prion Developmental Laboratories, a developer of diagnostic tools for Mad Cow Disease and a similar neurodegenerative disorder that affects deer and elk called Chronic Wasting Disease.
|
| | | Contact Information | |
Address: |
10940 Wilshire Blvd., Ste 600
Los Angeles, CA 90024
| | Phone: | 310-443-4102 | | Fax: | 310-443-4103 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1.30 M | | Employees (2008): | 17 |
|
|
Key People
| | • |
President, CEO, and Director:
Douglas Lane
|
|
|
